Get started
Verve Therapeutics, Inc.VV

Verve Therapeutics, Inc.

6.33USDR
+0.13+2.10%
At close at Feb 28, 22:34 GMT
USD
No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Forecast Seasonals
Back

Operating expenses (excl. COGS) of Verve Therapeutics, Inc.

Annual data
2020
2021
2022
2023
2024
TTM
‪‪−280.00 M‬‬
‪‪−210.00 M‬‬
‪‪−140.00 M‬‬
‪‪−70.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
TTM
‪‪−254.24 M‬‬
‪0.00‬
‪0.00‬%
2024
‪‪−254.24 M‬‬
‪‪−24.81 M‬‬
‪−10.81‬%
2023
‪‪−229.43 M‬‬
‪‪−68.51 M‬‬
‪−42.57‬%
2022
‪‪−160.92 M‬‬
‪‪−77.23 M‬‬
‪−92.28‬%
2021
‪‪−83.69 M‬‬
‪‪−44.39 M‬‬
‪−112.96‬%
2020
‪‪−39.30 M‬‬
‪‪−25.76 M‬‬
‪−190.33‬%
Quarterly data
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−68.00 M‬‬
‪‪−51.00 M‬‬
‪‪−34.00 M‬‬
‪‪−17.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
Q4 '24
‪‪−67.45 M‬‬
‪‪−5.43 M‬‬
‪−8.75‬%
Q3 '24
‪‪−62.02 M‬‬
+‪‪1.84 M‬‬
+‪2.89‬%
Q2 '24
‪‪−63.86 M‬‬
‪‪−2.96 M‬‬
‪−4.85‬%
Q1 '24
‪‪−60.91 M‬‬
‪‪−3.33 M‬‬
‪−5.79‬%
Q4 '23
‪‪−57.58 M‬‬
‪‪−5.32 M‬‬
‪−10.19‬%
Q3 '23
‪‪−52.25 M‬‬
+‪‪5.40 M‬‬
+‪9.36‬%
Q2 '23
‪‪−57.65 M‬‬
‪‪−746.00 K‬‬
‪−1.31‬%
Q1 '23
‪‪−56.90 M‬‬
‪‪−10.73 M‬‬
‪−23.25‬%
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20